Hydroxyurea is associated with lower malaria incidence in children with sickle cell anemia in sub-Saharan Africa.Olupot-Olupot P, Tomlinson G, Williams TN, Tshilolo LMM, Santos B, Smart LR, McElhinney K, Howard TA, Aygun B, Stuber SE, Lane A, Latham T, Ware RE
Blood, (2022). 141:1402-1410

Subphenotypes of sickle cell disease in Africa.Piel FB, Williams TN
Blood, (2017). 130:2157-2158

Combinatorial effects of malaria season, iron deficiency, and inflammation determine plasma hepcidin concentration in African children.Atkinson SH, Armitage AE, Khandwala S, Mwangi TW, Uyoga S, Bejon PA, Williams TN, Prentice AM, Drakesmith H
Blood, (2014). 123:3221-9

Epistasis between the haptoglobin common variant and alpha+thalassemia influences risk of severe malaria in Kenyan children.Atkinson SH, Uyoga SM, Nyatichi E, Macharia AW, Nyutu G, Ndila C, Kwiatkowski DP, Rockett KA, Williams TN
Blood, (2014). 123:2008-16

High mortality from Plasmodium falciparum malaria in children living with sickle cell anemia on the coast of Kenya.McAuley CF, Webb C, Makani J, Macharia A, Uyoga S, Opi DH, Ndila C, Ngatia A, Scott JA, Marsh K, Williams TN
Blood, (2010). 116:1663-8

Malaria in patients with sickle cell anemia: burden, risk factors, and outcome at the outpatient clinic and during hospitalization.Makani J, Komba AN, Cox SE, Oruo J, Mwamtemi K, Kitundu J, Magesa P, Rwezaula S, Meda E, Mgaya J, Pallangyo K, Okiro E, Muturi D, Newton CR, Fegan G, Marsh K, Williams TN
Blood, (2010). 115:215-20

Both heterozygous and homozygous alpha+ thalassemias protect against severe and fatal Plasmodium falciparum malaria on the coast of Kenya.Williams TN, Wambua S, Uyoga S, Macharia A, Mwacharo JK, Newton CR, Maitland K
Blood, (2005). 106:368-71